Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response

Overview of attention for article published in Frontiers in immunology, August 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 57 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 5,912 followers.

RT @_cfcd: HER2-pulsed Dendritic Cells boost the efficacy of anti-PD1 therapy in HER2 expressing mammary carcinoma through the activation o…

24 Sep 2019

Reply Repost Favourite

HER2-pulsed Dendritic Cells boost the efficacy of anti-PD1 therapy in HER2 expressing mammary carcinoma through the activation of CD4 T cells. @FrontImmunol https://t.co/SveL5Q05UI

24 Sep 2019

Reply Repost Favourite

SPOTLIGHT: Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role ... @MoffittResearch https://t.co/5n5lRkqqIj Original study published in Frontiers in Immunology

20 Sep 2019

Reply Repost Favourite

RT @DCell_papers: Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and…

03 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.